Editorial: Pharmacogenomics of drug hypersensitivity reactions
Frontiers in Pharmacology · 26.06.2026 · 17
DOI: 10.3389/fphar.2026.1913346 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.06.2026. Verfasst von Yaya Kassogue und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche et de Formation sur les Pathologies Moléculaires, Faculté de Médecine et d'Odonto-Stomatologie, Université des Sciences, des Tech…. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug hypersensitivity reactions (DHRs) constitute 10% of all adverse drug reactions (ADRs), and 10 they are of significant concern due to the risk of serious morbidity and mortality [1]. The main 11 challenge associated with in this type of ADRs is their unpredictability and the potential life-12 threatening nature of severe reactions [2]. Therefore, it is critically important to provide scientific 13 information about the study of pharmacogenomic biomarkers related to these DHRs as well as the 14 safety and economic issues involved in their implementation in clinical practice; novel diagnostic 15 methods and genetic tests for the identification of the pharmacogenomic biomarkers, including 16 bioinformatic studies; and relevant information for the pathophysiology of the hypersensitivity 17 reactions. 18This Research Topic addressed important unmet needs in the improvement of the drug's safety 19through the compilation of research information on the mechanisms that cause these immunological 20 responses to drugs, to improve their diagnosis, to contribute to their management strategies, and to 21 look for those biomarkers that could predict these reactions in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre de Recherche et de Formation sur les Pathologies Moléculaires, Faculté de Médecine et d'Odonto-Stomatologie, Université des Sciences, des Techniques et des Technologies de Bamako, Bamako, Mali.
- Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Zitieren
APA
Kassogue, Y., & Fricke-Galindo, I. (2026). Editorial: Pharmacogenomics of drug hypersensitivity reactions. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1913346
Vancouver
Kassogue Y, Fricke-Galindo I. Editorial: Pharmacogenomics of drug hypersensitivity reactions. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1913346
BibTeX
@article{Kassogue2026,
author = {Kassogue, Yaya and Fricke-Galindo, Ingrid},
title = {Editorial: Pharmacogenomics of drug hypersensitivity reactions},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1913346}
}
EUVIMED